These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14941381)

  • 1. Remission in a case of myasthenia gravis following the use of acth.
    DITTLER EL
    N Y State J Med; 1952 Jun; 52(12):1565. PubMed ID: 14941381
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of adrenocorticotrophic hormone in the treatment of myasthenia gravis.
    SHAPIRO SK
    Minn Med; 1951 Dec; 34(12):1160-4. PubMed ID: 14890619
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of severe cases of myasthenia; action of ACTH and cortisone, considerations apropos of three cases].
    LAMARTINE DE ASSIS J
    Arq Neuropsiquiatr; 1956 Mar; 14(1):28-36. PubMed ID: 13315056
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration.
    GROB D; HARVEY AM
    Bull Johns Hopkins Hosp; 1952 Aug; 91(2):124-36. PubMed ID: 14944967
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticotropin therapy and thymectomy in management of severe, generalized myasthenia gravis.
    Namba T; Shapiro MS; Brunner NG; Grob D
    Trans Am Neurol Assoc; 1970; 95():295-7. PubMed ID: 4328100
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment in myasthenic crisis induced by ACTH (author's transl)].
    Mozai T
    Kokyu To Junkan; 1975 Feb; 23(2):135-8. PubMed ID: 166424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of severe forms of myasthenia with intravenous ACTH].
    de ASSIS J
    Arq Neuropsiquiatr; 1960 Dec; 18():359-82. PubMed ID: 13684848
    [No Abstract]   [Full Text] [Related]  

  • 8. Myasthenia gravis treated with ACTH.
    Day J
    Nurs Times; 1967 Dec; 63(50):1695-6. PubMed ID: 4294739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H; Ott E; Aranibar A
    Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of myasthenia gravis].
    Jerusalem F
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
    [No Abstract]   [Full Text] [Related]  

  • 11. Endogenous ACTH induced remission in myasthenia gravis.
    Arbona NJ; Patterson SM; Cape CA
    Bull Los Angeles Neurol Soc; 1973 Oct; 38(4):183-7. PubMed ID: 4355567
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia gravis].
    Satoyoshi E; Nakazato H
    Naika; 1971 Jun; 27(6):1440-4. PubMed ID: 4326414
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship between negative and positive effects of ACTH treatment in myasthenia gravis.
    Pinelli P; Gandigli O G
    Electroencephalogr Clin Neurophysiol; 1968 Nov; 25(5):514. PubMed ID: 4182629
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal insufficiency in myasthenia gravis. A possible cause of adrenocorticotropic hormone (ACTH) treatment failure.
    Cape CA
    Bull Los Angeles Neurol Soc; 1972 Jul; 37(3):124-30. PubMed ID: 4339585
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myasthenia gravis. Recent findings and their therapeutic consequences].
    Thümler R; Haferkamp G
    Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ACTH on thymic masses.
    SOFFER LJ; GABRILOVE JL; WOLF BS
    J Clin Endocrinol Metab; 1952 Jun; 12(6):690-6. PubMed ID: 14927718
    [No Abstract]   [Full Text] [Related]  

  • 18. [ACTH or adrenocortical hormone therapy in myasthenia gravis, myotonia and herpes zoster].
    Takahashi A
    Horumon To Rinsho; 1968 Mar; 16(3):177-88. PubMed ID: 4300299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S; Ledro Molina D; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(2):139-44. PubMed ID: 6276943
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated corticotroph insufficiency associated to myasthenia gravis.
    Corcuff JB; Lafranque P; Henry P; Roger P
    J Endocrinol Invest; 1997 Dec; 20(11):669-71. PubMed ID: 9492106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.